LoginRegister

    Laurus Labs gets USFDA approval for diabetes drug

    Written by Ruby Khatun Khatun   |  
    Laurus Labs gets USFDA approval for diabetes drug

    New Delhi: Drug firm Laurus Labs said it has received approval from the US health regulator for its Metformin hydrochloride tablets used for the treatment of diabetes.


    The company has received approval from the United States Food and Drug Administration (USFDA) for Metformin hydrochloride tablets USP in the strengths of 500 mg, 850 mg, and 1,000 mg, Laurus Labs said in a BSE filing.


    The tablets are generic versions of Bristol-Myers Squibb Company's Glucophage tablets in the same strengths, it added.


    The product and API will be commercialized from company's Unit 2 located at Atchutapuram, Visakhapatnam in Andhra Pradesh, Laurus Labs said.

    Andhra PradeshAPIapprovalAtchutapuramBristol-Myers Squibbdiabetesdiabetes druggeneric versionsGlucophage tabletsLaurus LabsMetformin Hydrochloride tabletsUnited States Food and Drug AdministrationUSFDAVisakhapatnam
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X